Pacific Biosciences of California (PACB) stock news · rev $160.0M
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
This PACB news page leads with what Pacific Biosciences of California filed — not a scraped headline mill.
No cached 8-K sentence for PACB yet. We will not pad this page with generic market recap.
Latest reported PACB revenue for 2025-12-31 was $160.0M. Net income was -$546.4M. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. PACB currently screens at market cap $387.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PACB stock page; for the tape open the quote page.
PACB stock news FAQ
What are PACB's latest revenue and net income?
Latest cached Pacific Biosciences of California (PACB) revenue for Dec 31, 2025 was $160.0M. Net income was -$546.4M. Statements: https://lician.com/financials/pacb
How did PACB revenue change from the prior cached period?
Cached Pacific Biosciences of California (PACB) revenue was up 3.9% from $154.0M (Dec 31, 2024) to $160.0M (Dec 31, 2025). Statements: https://lician.com/financials/pacb
What is PACB's market cap?
Pacific Biosciences of California (PACB) market cap is $387.1M on the latest cached fundamentals snapshot.
What kind of company is PACB?
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Where is PACB stock news listed?
Cached stock news for Pacific Biosciences of California (PACB) is listed at https://lician.com/news/pacb. Filings: https://lician.com/sec/pacb
Not investment advice.